MedPath

Effectiveness of blood flow restriction after anterior cruciate ligament reconstructio

Recruiting
Conditions
ACL-rupture
Registration Number
NL-OMON20815
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
35
Inclusion Criteria

Bone-patella tendon-bone anterior cruciate ligament reconstruction
Post operative revalidation at Kniecentrum Plus

Exclusion Criteria

Known diabetes mellitus
Known sickle cell anemia
Known hypertension
Known renal disfunction
Known deep vein thrombosis
Any infection of the extremities
Known lymphadenectomy
Known carcinoma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quadriceps and hamstring strength 8 and 14 weeks after BPTB ACL reconstruction.
Secondary Outcome Measures
NameTimeMethod
eg muscle size, physical function, patient satisfaction, patient confidence, knee laxity, knee pain and knee effusion at 8-, 14-, 26-, 39- and 52- weeks after BPRB ACL reconstruction.<br>Furthermore, completion of revalidation and adverse events will be documented.
© Copyright 2025. All Rights Reserved by MedPath